Ignite Creation Date:
2024-05-05 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00304473
Status:
COMPLETED
Last Update Posted:
2009-03-25
First Post:
2006-03-17
Brief Title:
Fast Titration in the Treatment of Schizophrenia Taiwan
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Fast Titration of Quetiapine Versus Conventional Titration in the Treatment of SchizophreniaSchizoaffective Disorder a Randomised Parallel Group Open Trial
Status:
COMPLETED
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Assess the efficacy of a fast titration of quetiapine to the current titration approved by the regulatory authorities
PLEASE NOTE Seroquel SR and Seroquel XR refer to the same formulation The SR designation was changed to XR after consultation with FDA
PLEASE NOTE Seroquel SR and Seroquel XR refer to the same formulation The SR designation was changed to XR after consultation with FDA
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None